July 28, 2020 | COVID-19 Briefings

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Free COVID-19 STAT Intelligence Briefings Email Digest

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

FDA Releases Update of Test Substitution Tool Identifying Validated Supply Alternatives for SARS-CoV-2 Testing

FDA updates direction on alternative COVID-19 testing supplies

The FDA recently updated its interactive tool designed to assist in identifying COVID-19 testing supply alternatives.

New Meta-analysis Reveals Significant Weaknesses in Evidence Base for Point-of-Care SARS-CoV-2 Serology Tests

Clinical laboratories and meta-analysis recently published casts doubts on serology test performance, Abbott antigen test

New research casts doubt on the evidence that SARS-CoV-2 serology testing yields useful data.